Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 204

1.

Comparison of gastroesophageal reflux disease symptoms and proton pump inhibitor response using gastroesophageal reflux disease impact scale questionnaire.

Jo SY, Kim N, Lim JH, Shin CM, Park YS, Lee DH, Jung HC.

J Neurogastroenterol Motil. 2013 Jan;19(1):61-9. doi: 10.5056/jnm.2013.19.1.61. Epub 2013 Jan 8.

PMID:
23350049
[PubMed]
Free PMC Article
2.
3.

Association of sleep dysfunction and emotional status with gastroesophageal reflux disease in Korea.

Kim JY, Kim N, Seo PJ, Lee JW, Kim MS, Kim SE, Jo SY, Lee DH, Jung HC.

J Neurogastroenterol Motil. 2013 Jul;19(3):344-54. doi: 10.5056/jnm.2013.19.3.344. Epub 2013 Jul 8.

PMID:
23875102
[PubMed]
Free PMC Article
4.

How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?

de Bortoli N, Nacci A, Savarino E, Martinucci I, Bellini M, Fattori B, Ceccarelli L, Costa F, Mumolo MG, Ricchiuti A, Savarino V, Berrettini S, Marchi S.

World J Gastroenterol. 2012 Aug 28;18(32):4363-70. doi: 10.3748/wjg.v18.i32.4363.

PMID:
22969200
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.

Roorda AK, Marcus SN, Triadafilopoulos G.

Dig Dis Sci. 2011 Oct;56(10):2871-8. doi: 10.1007/s10620-011-1708-9. Epub 2011 Apr 22.

PMID:
21512760
[PubMed - indexed for MEDLINE]
6.

[Long-term impact on quality of life in patients with gastroesophageal reflux disease after 52-week rabeprazole treatment].

Yang XL, Liu XH, Ke MY, Song ZQ, Yuan YZ, Luo JY, Hou XH.

Zhonghua Yi Xue Za Zhi. 2009 Sep 15;89(34):2404-7. Chinese.

PMID:
20137694
[PubMed - indexed for MEDLINE]
7.

Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid.

Shapiro M, Green C, Bautista JM, Peru RL, Malagon IB, Corvo M, Risner-Adler S, Beeler JN, Tuchinsky I, Fass R.

Am J Gastroenterol. 2006 May;101(5):1084-91.

PMID:
16573776
[PubMed - indexed for MEDLINE]
8.

Quantitative assessment and characterization of visceral hyperalgesia evoked by esophageal balloon distention and acid perfusion in patients with functional heartburn, nonerosive reflux disease, and erosive esophagitis.

Yang M, Li ZS, Chen DF, Zou DW, Xu XR, Fang DC, Xu GM, Stephens RL, Wang ZG.

Clin J Pain. 2010 May;26(4):326-31. doi: 10.1097/AJP.0b013e3181c8fc83.

PMID:
20393268
[PubMed - indexed for MEDLINE]
9.

Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn.

Savarino E, Zentilin P, Mastracci L, Dulbecco P, Marabotto E, Gemignani L, Bruzzone L, de Bortoli N, Frigo AC, Fiocca R, Savarino V.

J Gastroenterol. 2013 Apr;48(4):473-82. doi: 10.1007/s00535-012-0672-2. Epub 2012 Sep 25.

PMID:
23001252
[PubMed - indexed for MEDLINE]
10.

Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn.

Kandulski A, Jechorek D, Caro C, Weigt J, Wex T, Mönkemüller K, Malfertheiner P.

Aliment Pharmacol Ther. 2013 Sep;38(6):643-51. doi: 10.1111/apt.12428. Epub 2013 Jul 29.

PMID:
23895770
[PubMed - indexed for MEDLINE]
11.

The Therapeutic and Diagnostic Value of 2-week High Dose Proton Pump Inhibitor Treatment in Overlapping Non-erosive Gastroesophageal Reflux Disease and Functional Dyspepsia Patients.

Kriengkirakul C, Patcharatrakul T, Gonlachanvit S.

J Neurogastroenterol Motil. 2012 Apr;18(2):174-80. doi: 10.5056/jnm.2012.18.2.174. Epub 2012 Apr 9.

PMID:
22523726
[PubMed]
Free PMC Article
12.

Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan.

Furuta T, Shimatani T, Sugimoto M, Ishihara S, Fujiwara Y, Kusano M, Koike T, Hongo M, Chiba T, Kinoshita Y; Acid-Related Symptom Research Group.

J Gastroenterol. 2011 Nov;46(11):1273-83. doi: 10.1007/s00535-011-0446-2. Epub 2011 Aug 24.

PMID:
21861141
[PubMed - indexed for MEDLINE]
13.

Reflux profile of Chinese gastroesophageal reflux disease patients with combined multichannel intraluminal impedance-pH monitoring.

Xiao YL, Lin JK, Cheung TK, Wong NY, Hung IF, Wong BC, Peng S, Wang AJ, Chen MH.

J Gastroenterol Hepatol. 2009 Jun;24(6):1113-8. doi: 10.1111/j.1440-1746.2009.05861.x.

PMID:
19638089
[PubMed - indexed for MEDLINE]
14.

Comparison of distribution of intraesophageal pH during nighttime recumbency among patients with gastroesophageal reflux disease.

Hershcovici T, Jha LK, Fass R.

J Clin Gastroenterol. 2012 Aug;46(7):562-6. doi: 10.1097/MCG.0b013e318248f631.

PMID:
22476040
[PubMed - indexed for MEDLINE]
15.

Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease.

Lee ES, Kim N, Lee SH, Park YS, Kim JW, Jeong SH, Lee DH, Jung HC, Song IS.

Aliment Pharmacol Ther. 2009 Jul 1;30(2):154-64. doi: 10.1111/j.1365-2036.2009.04021.x. Epub 2009 Apr 15.

PMID:
19392871
[PubMed - indexed for MEDLINE]
16.

More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy.

Kusano M, Hosaka H, Kawamura O, Kawada A, Kuribayashi S, Shimoyama Y, Yasuoka H, Mizuide M, Tomizawa T, Sagawa T, Sato K, Yamada M.

J Gastroenterol. 2014 Jun 12. [Epub ahead of print]

PMID:
24919745
[PubMed - as supplied by publisher]
17.

Incidence of gastroesophageal reflux disease in Uygur and Han Chinese adults in Urumqi.

Niu CY, Zhou YL, Yan R, Mu NL, Gao BH, Wu FX, Luo JY.

World J Gastroenterol. 2012 Dec 28;18(48):7333-40. doi: 10.3748/wjg.v18.i48.7333.

PMID:
23326142
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.

Pace F, Pace M.

Expert Rev Gastroenterol Hepatol. 2010 Aug;4(4):423-7. doi: 10.1586/egh.10.38.

PMID:
20678016
[PubMed - indexed for MEDLINE]
19.

Gastroesophageal reflux disease management according to contemporary international guidelines: a translational study.

Pace F, Riegler G, de Leone A, Dominici P, Grossi E; EMERGE Study Group.

World J Gastroenterol. 2011 Mar 7;17(9):1160-6. doi: 10.3748/wjg.v17.i9.1160.

PMID:
21448420
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease.

Nojkov B, Rubenstein JH, Adlis SA, Shaw MJ, Saad R, Rai J, Weinman B, Chey WD.

Aliment Pharmacol Ther. 2008 Mar 15;27(6):473-82. doi: 10.1111/j.1365-2036.2008.03596.x. Epub 2008 Jan 10.

PMID:
18194508
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk